Sarda Proteins Limited returned to profitability in the first quarter of FY26, reporting a net profit of ₹165.97 lakh for the period ended June 30, 2026. This marks a significant recovery from the net loss of ₹49.34 lakh recorded in the corresponding quarter of the previous year. Total revenue for the quarter stood at ₹1,847.40 lakh, a sharp increase compared to ₹1,095.54 lakh in Q1FY25, driven primarily by a rise in revenue from operations to ₹1,299.30 lakh.

The company's board approved the unaudited standalone financial results during a meeting held on July 15, 2026. The results were reviewed by the statutory auditor, A H Mandaliya & Associates, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The auditor confirmed that the statement complies with Indian Accounting Standard (Ind AS) 34 and contains no material misstatement.

Financial Performance

The turnaround in profitability was supported by a substantial increase in other income, which rose to ₹548.10 lakh from ₹0.08 lakh in the prior year quarter. Total expenses for the quarter were ₹1,626.10 lakh. The company reported a profit before tax of ₹221.30 lakh, with a current tax expense of ₹55.33 lakh recorded for the period.

Corporate Governance Decisions

Alongside the financial results, the board approved several key governance and administrative changes. Ms. Minal Surendra Jain was appointed as an Independent Women Director for a term of five years, effective July 15, 2026, subject to shareholder approval. The board also reconstituted the Audit Committee, Nomination and Remuneration Committee, and Stakeholders' Relationship Committee with immediate effect.

Administratively, the company approved the shifting of its registered office within Alwar, Rajasthan, to a new location effective July 15, 2026. Additionally, the board sanctioned the establishment of a new corporate office in Rajkot, Gujarat, commencing operations on the same date. The company noted that it operates in a single segment, the Renewable Energy Sector Solar Cell Products.

Sarda Proteins Limited has fixed July 23, 2026, as the cut-off date to determine shareholder eligibility for voting at its Extraordinary General Meeting (EGM) scheduled for July 30, 2026. The meeting, conducted via audio-visual means, will seek shareholder approval to increase the authorised share capital from ₹13 crore to ₹100 crore and change the company's name to Sarda Enterprises Limited to reflect its diversified business strategy. These moves are aimed at providing financial flexibility for growth and aligning the corporate identity with expanded operations.

The Board of Directors proposes to alter Clause V of the Memorandum of Association to facilitate the capital increase. This adjustment is intended to meet long-term capital requirements for business expansion and potential future fund-raising activities. The company also seeks to amend the main object clause to include activities related to agriculture, horticulture, and food processing, alongside its existing operations.

Shareholders will vote on the appointment and regularization of several key personnel. The Board recommends appointing Shirish Dhirajlal Savaliya as Managing Director for a period of five years effective July 4, 2026, with a monthly remuneration of ₹2,10,000. Additionally, Mr. Yagnik Satasiya is proposed to be designated as the Non-Executive Chairperson for a five-year term. The EGM will also confirm the appointments of Mr. Gunvantray Jayantilal Zaladi and Mr. Shivam Gunvantray Zaladi as Non-Executive, Non-Independent Directors.

The proposal to change the name to Sarda Enterprises Limited follows the Board's decision to diversify into various sectors. The company stated that the new name more appropriately reflects its current objectives and future growth plans. The change will not affect the legal status or continuity of the company or the rights of its members and creditors.

Remote e-voting for the meeting will commence on July 27, 2026, at 9:00 A.M. (IST) and conclude on July 29, 2026, at 5:00 P.M. (IST). Shareholders whose names appear in the Register of Members or the Register of Beneficial Owners as on the cut-off date of July 23, 2026, will be entitled to vote.